• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

创新纳米药物递送:靶向肿瘤微环境以克服耐药性。

Innovative Nanomedicine Delivery: Targeting Tumor Microenvironment to Defeat Drug Resistance.

作者信息

Meng Wenjun, Huang Li, Guo Jiamin, Xin Qing, Liu Jiyan, Hu Yuzhu

机构信息

Department of Radiation Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.

Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.

出版信息

Pharmaceutics. 2024 Dec 3;16(12):1549. doi: 10.3390/pharmaceutics16121549.

DOI:10.3390/pharmaceutics16121549
PMID:39771528
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11728492/
Abstract

Nanodrug delivery systems have revolutionized tumor therapy like never before. By overcoming the complexity of the tumor microenvironment (TME) and bypassing drug resistance mechanisms, nanotechnology has shown great potential to improve drug efficacy and reduce toxic side effects. This review examines the impact of the TME on drug resistance and recent advances in nanomedicine delivery systems to overcome this challenge. Characteristics of the TME such as hypoxia, acidity, and high interstitial pressure significantly reduce the effectiveness of chemotherapy and radiotherapy, leading to increased drug resistance in tumor cells. Then, this review summarizes innovative nanocarrier designs for these microenvironmental features, including hypoxia-sensitive nanoparticles, pH-responsive carriers, and multifunctional nanosystems that enable targeted drug release and improved drug penetration and accumulation in tumors. By combining nanotechnology with therapeutic strategies, this review offers a novel perspective by focusing on the innovative design of nanocarriers that interact with the TME, a dimension often overlooked in similar reviews. We highlight the dual role of these nanocarriers in therapeutic delivery and TME modulation, emphasize their potential to overcome drug resistance, and look at future research directions.

摘要

纳米药物递送系统彻底改变了肿瘤治疗,前所未有的变革。通过克服肿瘤微环境(TME)的复杂性并绕过耐药机制,纳米技术已显示出提高药物疗效和减少毒副作用的巨大潜力。本综述探讨了TME对耐药性的影响以及纳米医学递送系统为克服这一挑战所取得的最新进展。TME的特征,如缺氧、酸性和高间质压力,显著降低了化疗和放疗的效果,导致肿瘤细胞耐药性增加。然后,本综述总结了针对这些微环境特征的创新纳米载体设计,包括缺氧敏感纳米颗粒、pH响应载体以及能够实现靶向药物释放并改善药物在肿瘤中的渗透和积累的多功能纳米系统。通过将纳米技术与治疗策略相结合,本综述通过关注与TME相互作用的纳米载体的创新设计提供了一个新颖的视角,这是类似综述中经常被忽视的一个维度。我们强调了这些纳米载体在治疗递送和TME调节中的双重作用,强调了它们克服耐药性的潜力,并展望了未来的研究方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3163/11728492/21ce9c7f4a63/pharmaceutics-16-01549-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3163/11728492/c14b92958462/pharmaceutics-16-01549-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3163/11728492/ad158ef289b5/pharmaceutics-16-01549-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3163/11728492/225f96c182ba/pharmaceutics-16-01549-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3163/11728492/33a494d48b42/pharmaceutics-16-01549-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3163/11728492/159345564d8a/pharmaceutics-16-01549-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3163/11728492/21ce9c7f4a63/pharmaceutics-16-01549-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3163/11728492/c14b92958462/pharmaceutics-16-01549-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3163/11728492/ad158ef289b5/pharmaceutics-16-01549-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3163/11728492/225f96c182ba/pharmaceutics-16-01549-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3163/11728492/33a494d48b42/pharmaceutics-16-01549-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3163/11728492/159345564d8a/pharmaceutics-16-01549-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3163/11728492/21ce9c7f4a63/pharmaceutics-16-01549-g006.jpg

相似文献

1
Innovative Nanomedicine Delivery: Targeting Tumor Microenvironment to Defeat Drug Resistance.创新纳米药物递送:靶向肿瘤微环境以克服耐药性。
Pharmaceutics. 2024 Dec 3;16(12):1549. doi: 10.3390/pharmaceutics16121549.
2
Responsive Role of Nanomedicine in the Tumor Microenvironment and Cancer Drug Resistance.纳米医学在肿瘤微环境和癌症耐药性中的响应作用。
Curr Med Chem. 2023;30(29):3335-3355. doi: 10.2174/0929867329666220922111336.
3
T cell-mediated targeted delivery of tadalafil regulates immunosuppression and polyamine metabolism to overcome immune checkpoint blockade resistance in hepatocellular carcinoma.T 细胞介导的他达拉非靶向递药调节免疫抑制和多胺代谢,以克服肝癌的免疫检查点阻断耐药性。
J Immunother Cancer. 2023 Feb;11(2). doi: 10.1136/jitc-2022-006493.
4
Extensive Review of Nanomedicine Strategies Targeting the Tumor Microenvironment in PDAC.针对胰腺癌肿瘤微环境的纳米医学策略的广泛综述
Int J Nanomedicine. 2025 Mar 17;20:3379-3406. doi: 10.2147/IJN.S504503. eCollection 2025.
5
Nanomedicine-Enhanced Radiotherapy for Glioblastoma: Advances in Targeted Therapy and Adaptive Treatment Strategies.纳米医学增强胶质母细胞瘤放疗:靶向治疗与适应性治疗策略的进展
Pharmaceutics. 2025 Apr 11;17(4):508. doi: 10.3390/pharmaceutics17040508.
6
Current advances in nanoformulations of therapeutic agents targeting tumor microenvironment to overcome drug resistance.靶向肿瘤微环境以克服耐药性的治疗药物纳米制剂的当前进展。
Cancer Metastasis Rev. 2023 Sep;42(3):959-1020. doi: 10.1007/s10555-023-10119-w. Epub 2023 Jul 28.
7
Tumor microenvironment-regulating nanomedicine design to fight multi-drug resistant tumors.肿瘤微环境调控纳米医学设计以对抗多药耐药肿瘤。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 Jan;15(1):e1842. doi: 10.1002/wnan.1842. Epub 2022 Aug 21.
8
Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine.肿瘤酸度裂解马来酸酰胺(TACMAA):设计智能纳米粒子克服癌症纳米医学中输送障碍的强大工具。
Acc Chem Res. 2018 Nov 20;51(11):2848-2856. doi: 10.1021/acs.accounts.8b00195. Epub 2018 Oct 15.
9
Pathophysiology-Driven Approaches for Overcoming Nanomedicine Resistance in Pancreatic Cancer.基于病理生理学的胰腺癌纳米医学耐药性克服方法
Mol Pharm. 2024 Dec 2;21(12):5960-5988. doi: 10.1021/acs.molpharmaceut.4c00801. Epub 2024 Nov 19.
10
Advancements in pH-responsive nanocarriers: enhancing drug delivery for tumor therapy.pH响应性纳米载体的进展:增强用于肿瘤治疗的药物递送
Expert Opin Drug Deliv. 2023 Jul-Dec;20(11):1623-1642. doi: 10.1080/17425247.2023.2292678. Epub 2023 Dec 20.

引用本文的文献

1
The malignant dialogue between cancer-associated fibroblasts and osteosarcoma cells: microenvironment-mediated drug resistance and therapeutic targets.癌症相关成纤维细胞与骨肉瘤细胞之间的恶性对话:微环境介导的耐药性及治疗靶点
Front Immunol. 2025 Aug 20;16:1621521. doi: 10.3389/fimmu.2025.1621521. eCollection 2025.
2
Cell-in-cell associated lncRNA signature predicts prognosis and immunotherapy response in gastric cancer.细胞内细胞相关的长链非编码RNA特征预测胃癌的预后和免疫治疗反应。
Front Oncol. 2025 Jul 8;15:1597187. doi: 10.3389/fonc.2025.1597187. eCollection 2025.
3
Circadian-Tuned Peptide Drug/Gene Co-Delivery Nanocomplexes to Enhance Glioblastoma Targeting and Transfection.

本文引用的文献

1
Combination Nanodrug Delivery Systems Facilitate the Syncretism of Chemotherapy with Immunotherapy to Promote Cancer Treatment.组合纳米药物递送系统促进化疗与免疫疗法的融合以推动癌症治疗。
Small. 2025 Jan;21(2):e2405752. doi: 10.1002/smll.202405752. Epub 2024 Nov 15.
2
Sintilimab Combined with Nanoparticle Albumin-Bound Paclitaxel-Based Chemotherapy in Severe Locally Advanced or Metastatic Squamous NSCLC Showed Good Efficacy and Safety: A Pilot Retrospective Analysis.信迪利单抗联合白蛋白结合型紫杉醇化疗治疗重症局部晚期或转移性鳞状非小细胞肺癌的疗效和安全性良好:一项前瞻性回顾性分析。
Int J Nanomedicine. 2024 Nov 7;19:11433-11444. doi: 10.2147/IJN.S484765. eCollection 2024.
3
昼夜节律调节的肽药物/基因共递送纳米复合物增强胶质母细胞瘤靶向性和转染
Int J Mol Sci. 2025 Jun 26;26(13):6130. doi: 10.3390/ijms26136130.
4
Molecular markers for the efficacy of neoadjuvant immunotherapy for head and neck squamous cell carcinoma.头颈部鳞状细胞癌新辅助免疫治疗疗效的分子标志物
Front Oncol. 2025 Jun 23;15:1586130. doi: 10.3389/fonc.2025.1586130. eCollection 2025.
5
Effective imaging examination evaluation method for surgical pathological complete responds of head and neck squamous cell carcinoma after neoadjuvant immunochemotherapy.新辅助免疫化疗后头颈部鳞状细胞癌手术病理完全缓解的有效影像学检查评估方法
Front Oncol. 2025 Jun 10;15:1585194. doi: 10.3389/fonc.2025.1585194. eCollection 2025.
6
Heterogenous cancer-associated fibroblasts related tumor microenvironment marked by CD10/KLF4/TIAM1 were identified in pancreatic adenocarcinoma by integrated transcriptomics.通过整合转录组学在胰腺腺癌中鉴定出以CD10/KLF4/TIAM1为特征的异质性癌症相关成纤维细胞相关肿瘤微环境。
Front Immunol. 2025 Apr 14;16:1557698. doi: 10.3389/fimmu.2025.1557698. eCollection 2025.
Cocrystal@protein-anchoring nanococktail for combinatorially treating multidrug-resistant cancer.
用于联合治疗多药耐药癌症的共晶@蛋白质锚定纳米鸡尾酒
Acta Pharm Sin B. 2024 Oct;14(10):4509-4525. doi: 10.1016/j.apsb.2024.08.014. Epub 2024 Aug 17.
4
Protein arginine methyltransferase 5 confers the resistance of triple-negative breast cancer to nanoparticle albumin-bound paclitaxel by enhancing autophagy through the dimethylation of ULK1.蛋白精氨酸甲基转移酶 5 通过增强自噬来增加 ULK1 的二甲基化,从而赋予三阴性乳腺癌对白蛋白结合型紫杉醇纳米粒的耐药性。
Toxicol Appl Pharmacol. 2024 Dec;493:117145. doi: 10.1016/j.taap.2024.117145. Epub 2024 Nov 7.
5
Photothermally Reinforced Nanozyme Remodeling Tumor Microenvironment of Redox and Metabolic Homeostasis to Enhance Ferroptosis in Tumor Therapy.光热增强型纳米酶重塑肿瘤氧化还原和代谢稳态微环境以增强肿瘤治疗中的铁死亡
ACS Nano. 2024 Nov 19;18(46):32235-32254. doi: 10.1021/acsnano.4c13087. Epub 2024 Nov 5.
6
Omics-Enhanced Nanomedicine for Cancer Therapy.用于癌症治疗的组学增强型纳米医学
Adv Mater. 2024 Dec;36(50):e2409102. doi: 10.1002/adma.202409102. Epub 2024 Oct 30.
7
Efficacy and safety of nanoparticle albumin-bound paclitaxel plus carboplatin as neoadjuvant chemotherapy for stages III-IV, unresectable ovarian cancer: a single-arm, open-label, phase Ib/II study.白蛋白结合型紫杉醇联合卡铂作为 III-IV 期、不可切除卵巢癌新辅助化疗的疗效和安全性:一项单臂、开放标签、Ib/II 期研究。
BMC Med. 2024 Oct 29;22(1):496. doi: 10.1186/s12916-024-03697-1.
8
Reprogramming-based gene therapy promotes anti-tumor immunity in vivo.基于重编程的基因疗法可在体内促进抗肿瘤免疫。
Nat Genet. 2024 Oct;56(10):1999. doi: 10.1038/s41588-024-01956-8.
9
Biomimetic nanocarriers in cancer therapy: based on intercellular and cell-tumor microenvironment communication.仿生纳米载体在癌症治疗中的应用:基于细胞间和细胞-肿瘤微环境通讯。
J Nanobiotechnology. 2024 Oct 6;22(1):604. doi: 10.1186/s12951-024-02835-4.
10
An insight into impact of nanomaterials toxicity on human health.纳米材料毒性对人类健康影响的深入洞察。
PeerJ. 2024 Sep 30;12:e17807. doi: 10.7717/peerj.17807. eCollection 2024.